Jerry Kolaja

Jerry’s formal training includes a DVM from Michigan State University and a PhD in pathology from the University of Maryland Medical School. He is board certified in Veterinary Pathology and has extensive experience in developing pharmaceuticals for human use. His expertise is in toxicology and toxicologic pathology derived from training and experience in the military, pharmaceutical industry and as a consultant. He has played a significant role at the Upjohn Company, Pharmacia and Upjohn, Immunex and Amgen in the early characterization of compounds being selected for development.

Jerry also planned and supervised the pre-clinical programs for filing INDs and NDAs for several of these compounds. In his consulting practice, he routinely collaborates with pharmaceutical companies on lead selection and development as well as investigative toxicology. He has extensive experience in toxicology and pathology at both the scientific level as well as in management, being the Vice President for Toxicology Operations for Pharmacia and Upjohn.